Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Carbapenemase-Producing Extraintestinal Pathogenic Escherichia coli From Argentina: Clonal Diversity and Predominance of Hyperepidemic Clones CC10 and CC131

Frontiers in Microbiology(2022)10.3389/fmicb.2022.830209Source: DataRank Database

Carbapenemase-Producing Extraintestinal Pathogenic Escherichia coli From Argentina: Clonal Diversity and Predominance of Hyperepidemic Clones CC10 and CC131 is a research paper published in Frontiers in Microbiology (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

bioproject

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.99)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (4)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Denise De Belder ORCID,JM de Mendieta,Diego Faccone ORCID,Tomás Poklépovich ORCID,Celeste Lucero ORCID

Live enrichment

PubMed:35369469 PMC:PMC8971848 OpenAlex:https://openalex.org/W4220716554

National Institutes of Health

Grant: 1R56AI118756-01A1

Newly Identified mechanisms of Ceftaroline Resistance in MRSA Clinical Strains

FWCI

0.99

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.830209/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.830209/pdf

journalhttps://doi.org/10.3389/fmicb.2022.830209

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35369469

repositoryhttps://doaj.org/article/404ba22396914c3f8a66b39f99693893

Fields of Study

Antibiotic Resistance in BacteriaEscherichia coli research studiesEnterobacteriaceae and Cronobacter Research0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

BiologyMicrobiologyEscherichia coliVirulenceclone (Java method)GenomeGeneGeneticsPhylogenyCarbapenemaseExpecHigh Risk CloneFOS: Basic medicineGlobal Challenge of Antibiotic Resistance in BacteriaEndocrinologyhttps://purl.org/becyt/ford/3.3Biochemistry, Genetics and Molecular BiologyOutbreak of Cronobacter sakazakii Infectionshttps://purl.org/becyt/ford/3Pathogenesis and Virulence of Escherichia coliESKAPE PathogensLife SciencesCarbapenemasesQR1-502FOS: Biological sciencesMolecular Medicine

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 6: 6. Clean waterSDG 0: Good health and well-being

Carbapenemase-Producing Extraintestinal Pathogenic Escherichia coli From Argentina: Clonal Diversity and Predominance of Hyperepidemic Clones CC10 and CC131

FAIR Checklist

Authors (13)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)